NOVEL CRYSTALLINE FORM OF 1-(8-BROMOPYRIDO[2,3- E][1,2,4]TRIAZOLO[4,3-A]PYRAZIN-4-YL)-NMETHYLAZETIDIN- 3-AMINE
Application
US20260085071A1
Kind: A1
Mar 26, 2026
Inventors
Suha PARK, Seiho CHIN, Sumin LEE
Abstract
Novel crystalline forms of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-N-methylazetidin-3-amine is provided along with pharmaceutical compositions comprising the same. Also disclosed is the use of the novel polymorph for the treatment of diseases, such as atopic dermatitis (AD), itch, pruritus and various forms of urticaria for example chronic idiopathic urticaria subtypes.
CPC Classifications
C07D 471/14
A61K 31/4985
Filing Date
2023-09-29
Application No.
19110267